How to Spin Out a (Biotech) Company at the University of Cambridge: A BBMS x E-Lab Roundtable
Join us for a roundtable hosted by the Building Bridges in Medical Sciences Society, held in collaboration with the King’s E-Lab.
Speaker Bios:
Bernard Cho is a health data scientist and founder/CEO of Med Arcade, where he is building clinical AI software to simplify patient data and amplify health and care through precision medicine. He holds a PhD in Clinical Neurosciences and previously helped set up genetic labs globally. Bernard has taken part in several startup accelerators, including EF, EWOR and most recently SPARK 1.0.
Jenny Button is the Founder and CEO of Emm, a UK-based biowearable technology company developing a smart menstrual health device designed to provide objective, personalised data on menstrual flow and cycle health. She founded Emm in 2020 with the aim of closing the long-standing data gap in women’s health by combining medical-grade materials with advanced sensor technology in a connected wearable format. Under her leadership, the company has raised significant seed funding to bring its flagship product to market and is positioning itself at the forefront of next-generation femtech innovation.
Stefan Galander is an Investment Associate at Cambridge Enterprise, where he supports the commercialisation of life science innovations emerging from the University of Cambridge. With a background in cell biology and a PhD from the University of Edinburgh, he combines scientific expertise with venture investment experience, having previously worked at Cambridge Innovation Capital and Sana Capital. His role focuses on identifying and supporting high-potential spinouts at the intersection of research and entrepreneurship.
WHEN: Tuesday 10 March 2026
7.00 - 8.00 PM: Panel discussion in Keynes Lecture Theatre
WHERE: King’s College, Cambridge
TICKETS: Register here.